전립선 생검용 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 시술 어프로치별, 영상 유도 기술별, 최종사용자별, 지역별 및 부문별 예측(2026-2033년)

Prostate Biopsy Devices Market Summary

The global prostate biopsy devices market size was valued at USD 839.0 million in 2025 and is projected to grow from USD 906.1 million in 2026 to USD 1,563.0 million by 2033, at a CAGR of 8.1% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.3% in 2025. The prostate biopsy device industry's growth is driven by the increasing prevalence of prostate disorders, growing awareness of the importance of early cancer detection, and rising adoption of advanced diagnostic technologies.

The shift toward minimally invasive biopsy procedures, coupled with improvements in imaging-guided techniques such as MRI-ultrasound fusion and transperineal biopsy, is enhancing diagnostic accuracy and patient safety. Favorable clinical guidelines promoting targeted biopsy approaches, expanding healthcare infrastructure, and greater access to urology services are further supporting market growth. In addition, continuous technological advancements, including disposable biopsy instruments, robotic-assisted systems, and precision-guided biopsy platforms, are improving procedural efficiency and clinical outcomes.

The rising prevalence of prostate cancer is a key factor driving the growth of the prostate biopsy device market, as an increasing number of men require confirmatory diagnostic procedures following suspicious screening results or clinical findings. Prostate biopsy remains the gold standard for obtaining tissue samples to confirm the presence and severity of cancer, making biopsy devices essential in the diagnostic pathway. As the incidence of prostate cancer continues to rise globally, healthcare providers are performing a greater volume of biopsy procedures to enable early diagnosis and appropriate treatment planning. The growing disease burden is also placing greater emphasis on accurate, efficient biopsy techniques that improve cancer detection and support better clinical outcomes. In addition, increasing prostate cancer diagnoses are encouraging healthcare facilities to expand their diagnostic capabilities and invest in advanced biopsy technologies, resulting in sustained demand for prostate biopsy devices.

Global Prostate Biopsy Device Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the prostate biopsy device market report based on Product, procedure approach, imaging guidance technology, end user, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biopsy Guidance Systems (Capital Equipment)
  • Conventional Ultrasound-Guided Biopsy Systems
  • TRUS biopsy guidance systems
  • Ultrasound biopsy navigation systems
  • MRI-Ultrasound Fusion Biopsy Systems
  • Hardware-based fusion platforms (electromagnetic/mechanical)
  • Software-based fusion platforms
  • Micro-Ultrasound Biopsy Systems
  • In-Bore MRI Biopsy Guidance Systems
• Biopsy Access Devices
  • Transperineal Access Systems
  • Freehand transperineal access devices
  • Template/grid-based transperineal systems
  • Transrectal Needle Guide Systems
  • Disposable needle guides
  • Probe-mounted biopsy guides
• Tissue Acquisition & Sampling Devices
  • Biopsy Drivers / Mechanisms
  • Reusable biopsy guns
  • Fully single-use/disposable biopsy instruments (integrated handle + needle)
  • Standalone Core Biopsy Needles (For use with reusable guns or coaxial kits)
  • 16G biopsy needles
  • 18G biopsy needles
  • Other gauge biopsy needles
  • Cannula
• Procedure Approach Outlook (Revenue, USD Million, 2021 - 2033)
• Transrectal Prostate Biopsy (TRUS)
• Transperineal Prostate Biopsy (TP)
• Imaging Guidance Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Conventional Ultrasound-Guided
• MRI-Ultrasound Fusion-Guided
• Micro-Ultrasound Guided
• MRI-Guided
• In-Bore MRI-Guided
• End User Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Urology Clinics
• Diagnostic & Imaging Centers
• Academic & Research Institutes
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Procedure Approach
  • 1.1.3. Imaging Guidance Technology
  • 1.1.4. End User
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Prostate Biopsy Device Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of prostate cancer worldwide
    • 3.2.1.2. Increasing adoption of minimally invasive biopsy procedures
    • 3.2.1.3. Growing utilization of MRI-ultrasound fusion technologies
    • 3.2.1.4. Expanding awareness of early prostate cancer diagnosis
    • 3.2.1.5. Favorable reimbursement for advanced biopsy procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced biopsy guidance systems
    • 3.2.2.2. Limited accessibility in resource-constrained healthcare settings
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Expanding adoption of transperineal biopsy procedures globally
    • 3.2.3.2. Emerging markets investing in advanced diagnostic technologies
    • 3.2.3.3. Integration of artificial intelligence into biopsy workflows
    • 3.2.3.4. Growing demand for disposable biopsy instruments
    • 3.2.3.5. Development of compact and portable biopsy systems
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Maintaining diagnostic accuracy across diverse patient populations
    • 3.2.4.2. Managing workflow integration with existing imaging platforms
• 3.3. Prostate Biopsy Device Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Prostate Biopsy Device Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Prostate Biopsy Device Market: Product Movement Analysis & Market Share, 2021 & 2033
• 4.3. Biopsy Guidance Systems (Capital Equipment)
  • 4.3.1. Biopsy Guidance Systems (Capital Equipment) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Conventional Ultrasound-Guided Biopsy Systems
    • 4.3.2.1. Conventional Ultrasound-Guided Biopsy Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2. TRUS biopsy guidance systems
      • 4.3.2.2.1. TRUS Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3. Ultrasound Biopsy Navigation Systems
      • 4.3.2.3.1. Ultrasound Biopsy Navigation Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. MRI-Ultrasound Fusion Biopsy Systems
    • 4.3.3.1. MRI-Ultrasound Fusion Biopsy Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.2. Hardware-Based Fusion Platforms (Electromagnetic/Mechanical)
      • 4.3.3.2.1. Hardware-Based Fusion Platforms (Electromagnetic/Mechanical) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.3. Software-Based Fusion Platforms
      • 4.3.3.3.1. Software-Based Fusion Platforms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Micro-Ultrasound Biopsy Systems
    • 4.3.4.1. Micro-Ultrasound Biopsy Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.5. In-Bore MRI Biopsy Guidance Systems
    • 4.3.5.1. In-Bore MRI Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Biopsy Access Devices
  • 4.4.1. Biopsy Access Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Transperineal Access Systems
    • 4.4.2.1. Transperineal Access Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. Freehand Transperineal Access Devices
      • 4.4.2.2.1. Freehand Transperineal Access Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. Template/Grid-Based Transperineal Systems
      • 4.4.2.3.1. Template/Grid-Based Transperineal Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Transrectal Needle Guide Systems
    • 4.4.3.1. Transrectal Needle Guide Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Disposable Needle Guides
      • 4.4.3.2.1. Disposable Needle Guides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Probe-Mounted Biopsy Guides
      • 4.4.3.3.1. Probe-Mounted Biopsy Guides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Tissue Acquisition & Sampling Devices
  • 4.5.1. Tissue Acquisition & Sampling Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Biopsy Drivers / Mechanisms
    • 4.5.2.1. Biopsy Drivers / Mechanisms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.2. Reusable Biopsy Guns
      • 4.5.2.2.1. Reusable Biopsy Guns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.3. Fully Single-Use/Disposable Biopsy Instruments (Integrated Handle + Needle)
      • 4.5.2.3.1. Fully Single-Use/Disposable Biopsy Instruments (Integrated Handle + Needle) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Standalone Core Biopsy Needles (For use with reusable guns or coaxial kits)
    • 4.5.3.1. Standalone Core Biopsy Needles (For use with reusable guns or coaxial kits) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.2. 16G Biopsy Needles
      • 4.5.3.2.1. 16G Biopsy Needles Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.3. 18G Biopsy Needles
      • 4.5.3.3.1. 18G Biopsy Needles Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.4. Other Gauge Biopsy Needles
      • 4.5.3.4.1. Other Gauge Biopsy Needles Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Cannula
    • 4.5.4.1. Cannula Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Prostate Biopsy Device Market: Procedure Approach Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Prostate Biopsy Device Market: Procedure Approach Movement Analysis & Market Share, 2021 & 2033
• 5.3. Transrectal Prostate Biopsy (TRUS)
  • 5.3.1. Transrectal Prostate Biopsy (TRUS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Transperineal Prostate Biopsy (TP)
  • 5.4.1. Transperineal Prostate Biopsy (TP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Prostate Biopsy Device Market: Imaging Guidance Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Prostate Biopsy Device Market: Imaging Guidance Technology Movement Analysis & Market Share, 2021 & 2033
• 6.3. Conventional Ultrasound-Guided
  • 6.3.1. Conventional Ultrasound-Guided Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. MRI-Ultrasound Fusion-Guided
  • 6.4.1. MRI-Ultrasound Fusion-Guided Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Micro-Ultrasound Guided
  • 6.5.1. Micro-Ultrasound Guided Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. MRI-Guided
  • 6.6.1. MRI-Guided Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. In-Bore MRI-Guided
  • 6.7.1. In-Bore MRI-Guided Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Prostate Biopsy Device Market: End User Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Prostate Biopsy Device Market: End User Movement Analysis & Market Share, 2021 & 2033
• 7.3. Hospitals
  • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Ambulatory Surgical Centers (ASCs)
  • 7.4.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Specialty Urology Clinics
  • 7.5.1. Specialty Urology Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Diagnostic & Imaging Centers
  • 7.6.1. Diagnostic & Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Academic & Research Institutes
  • 7.7.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Prostate Biopsy Device Market: Regional Estimates & Trend Analysis by Product, by Procedure Approach, by Imaging Guidance Technology, by End User

• 8.1. Regional Outlook
• 8.2. Prostate Biopsy Device Market: Regional Movement Analysis & Market Share, 2021 & 2033
• 8.3. North America
  • 8.3.1. North America Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Scenario
    • 8.3.2.4. Reimbursement Scenario
    • 8.3.2.5. U.S. Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Scenario
    • 8.3.3.4. Reimbursement Scenario
    • 8.3.3.5. Canada Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Scenario
    • 8.3.4.4. Reimbursement Scenario
    • 8.3.4.5. Mexico Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Scenario
    • 8.4.2.4. Reimbursement Scenario
    • 8.4.2.5. UK Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Scenario
    • 8.4.3.4. Reimbursement Scenario
    • 8.4.3.5. Germany Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Scenario
    • 8.4.4.4. Reimbursement Scenario
    • 8.4.4.5. France Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Scenario
    • 8.4.5.4. Reimbursement Scenario
    • 8.4.5.5. Italy Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Scenario
    • 8.4.6.4. Reimbursement Scenario
    • 8.4.6.5. Spain Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Scenario
    • 8.4.7.4. Reimbursement Scenario
    • 8.4.7.5. Denmark Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Scenario
    • 8.4.8.4. Reimbursement Scenario
    • 8.4.8.5. Sweden Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Scenario
    • 8.4.9.4. Reimbursement Scenario
    • 8.4.9.5. Norway Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Scenario
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. Japan Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Scenario
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. China Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Scenario
    • 8.5.4.4. Reimbursement Scenario
    • 8.5.4.5. India Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Scenario
    • 8.5.5.4. Reimbursement Scenario
    • 8.5.5.5. South Korea Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Scenario
    • 8.5.6.4. Reimbursement Scenario
    • 8.5.6.5. Australia Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Scenario
    • 8.5.7.4. Reimbursement Scenario
    • 8.5.7.5. Thailand Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Scenario
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. Brazil Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Scenario
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Argentina Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Scenario
    • 8.7.2.4. Reimbursement Scenario
    • 8.7.2.5. South Africa Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Scenario
    • 8.7.3.4. Reimbursement Scenario
    • 8.7.3.5. Saudi Arabia Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Scenario
    • 8.7.4.4. Reimbursement Scenario
    • 8.7.4.5. UAE Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Scenario
    • 8.7.5.4. Reimbursement Scenario
    • 8.7.5.5. Kuwait Prostate Biopsy Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
• 9.4. Global Key company market share analysis, 2025
  • 9.4.1. BD
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. KOELIS (InnovaHealth Partners)
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Exact Imaging
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Biobot Surgical
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Focal Healthcare
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. GE HealthCare
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Koninklijke Philips N.V.
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. CANON MEDICAL SYSTEMS
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. FUJIFILM Healthcare
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Esaote SPA
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Siemens Healthcare Private Limited
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Financial Performance
    • 9.4.11.3. Product Benchmarking
    • 9.4.11.4. Strategic Initiatives
  • 9.4.12. Argon Medical Devices (Shandong Weigao Group Medical Polymer Co)
    • 9.4.12.1. Company Overview
    • 9.4.12.2. Financial Performance
    • 9.4.12.3. Product Benchmarking
    • 9.4.12.4. Strategic Initiatives
  • 9.4.13. Merit Medical Systems
    • 9.4.13.1. Company Overview
    • 9.4.13.2. Financial Performance
    • 9.4.13.3. Product Benchmarking
    • 9.4.13.4. Strategic Initiatives
  • 9.4.14. Cook
    • 9.4.14.1. Company Overview
    • 9.4.14.2. Financial Performance
    • 9.4.14.3. Product Benchmarking
    • 9.4.14.4. Strategic Initiatives
  • 9.4.15. Uromed (LABORIE Medical Technologies)
    • 9.4.15.1. Company Overview
    • 9.4.15.2. Financial Performance
    • 9.4.15.3. Product Benchmarking
    • 9.4.15.4. Strategic Initiatives
  • 9.4.16. TSK Laboratory
    • 9.4.16.1. Company Overview
    • 9.4.16.2. Financial Performance
    • 9.4.16.3. Product Benchmarking
    • 9.4.16.4. Strategic Initiatives
  • 9.4.17. STERYLAB
    • 9.4.17.1. Company Overview
    • 9.4.17.2. Financial Performance
    • 9.4.17.3. Product Benchmarking
    • 9.4.17.4. Strategic Initiatives
  • 9.4.18. BXTA (Elysian Capital)
    • 9.4.18.1. Company Overview
    • 9.4.18.2. Financial Performance
    • 9.4.18.3. Product Benchmarking
    • 9.4.18.4. Strategic Initiatives
  • 9.4.19. CIVCO Medical Solutions (Roper Technologies)
    • 9.4.19.1. Company Overview
    • 9.4.19.2. Financial Performance
    • 9.4.19.3. Product Benchmarking
    • 9.4.19.4. Strategic Initiatives
  • 9.4.20. Leapmed Healthcare
    • 9.4.20.1. Company Overview
    • 9.4.20.2. Financial Performance
    • 9.4.20.3. Product Benchmarking
    • 9.4.20.4. Strategic Initiatives
  • 9.4.21. Perineologic
    • 9.4.21.1. Company Overview
    • 9.4.21.2. Financial Performance
    • 9.4.21.3. Product Benchmarking
    • 9.4.21.4. Strategic Initiatives
  • 9.4.22. Others
• 9.5. Heat Map Analysis/ Company Market Position Analysis
• 9.6. Estimated Company Market Share Analysis, 2025
• 9.7. List of Other Key Market Players